DNLaunch Value Lab
Price domains with buyer-ready signals.
Evaluate a domain through three distinct lenses: end-user commercial potential, pure brand strength, and investor liquidity. The model also checks matching extensions, then treats that coverage as both a demand signal and a possible crowding risk.
Commercial intent
Brand strength
Investor liquidity
Extension demand
57
transmedix.com · Developable brand name
Speculative asset · 57 / 99
This score separates commercial usefulness, buyer depth, brandability, investor liquidity, extension quality, and matching-extension coverage. Confidence: Higher.
Best lens: Pure brand strength
3 of 27 checked extensions show DNS presence. This supports scarcity and market interest, while the collision score reflects possible crowding.
End-user potential50/99commercial clarity + buyer depth
Pure brand strength81/99memorability + extension
Investor liquidity59/99shortness + resale patterns
Retail estimate
$5,400 – $16,800
Wholesale estimate
$800 – $2,400
Brandability81
Commercial intent37
Buyer depth42
Investor liquidity50
Extension quality98
Market coverage50
Matching extensions
Early extension signalDNS presence is a useful demand proxy, not proof of an active company or trademark. Collision risk: 31 / 99.
.net.online.site
Likely buyer uses
medical, clinical, or healthcare products
Value drivers
- Developable brand name
- .COM extension score: 98/99
- 10-character name with clean spelling
- commercial keywords: med
- 3 of 27 other extensions show DNS presence
- high-signal coverage: .net
- asking price used as a 20% anchor, not copied as the appraisal
Risks and limitations
- The buyer story is not immediately obvious, so development or strong positioning may be required.